Experienced. Dedicated. Determined.

The team at Meissa is dedicated and determined to advance life-saving vaccines against respiratory viruses. Our team brings more than 200 years of experience from discovery to commercial stage for vaccine development. Collectively our team has completed more than 100 clinical trials and been involved in the development of 15 approved products.

Meissa Vaccines - Chosen-28 website.jpeg

Marty Moore Ph.D.

Founder and Chief Executive Officer

Karen Slobod, M.D.

Acting Chief Medical Officer

Janelle Muranaka

Vice President of Operations

William (Bill) Daly, J.D., MBA

Chief Business Officer

Keith H. Wells, Ph.D.

Chief Manufacturing Officer

Oliver Medzihradsky, M.D., M.P.H., M.S.

Senior Director of Clinical Development

Roderick Tang, Ph.D.

Founder and Chief Scientific Officer

Fiona Cameron

Vice President of Regulatory Affairs